Diakonos Oncology Corporation
3 clinical trials · Sponsor
◉ Watch Diakonos Oncology Corporation
| Record | Firm | Date |
|---|---|---|
| Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma (NCT04157127) | Diakonos Oncology Corporation | 2020-08-03 |
Track Diakonos Oncology Corporation automatically
Every clearance here is in the API, with alerts when new ones post.